Validation of the EUTOS Long-Term Survival Score in Chinese Chronic Myeloid Leukemia Patients Treated with Imatinib: A Multicenter Real-World Study
Xiawan Yang, 1,* Yanliang Bai, 1,* Mingyue Shi, 1 Wanjun Zhang, 1 Junwei Niu, 1 Chengye Wu, 2 Lei Zhang, 2 Zhiwei Xu, 3 Xiang Liu, 4 Yuqing Chen, 1 Kai Sun 1 1Department of Hematology, Zhengzhou University People’s Hospital and Henan Provincial People’s Hospital, Henan, People&a...
Main Authors: | Yang X, Bai Y, Shi M, Zhang W, Niu J, Wu C, Zhang L, Xu Z, Liu X, Chen Y, Sun K |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-02-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/validation-of-the-eutos-long-term-survival-score-in-chinese-chronic-my-peer-reviewed-article-CMAR |
Similar Items
-
A comparative study of Hasford score and Sokal index in prognostication of the novo chronic myeloid leukemia patients and a search for new prognostic markers
by: Swapan Kumar Sinha, et al.
Published: (2013-01-01) -
Prognostic Factors for Overall Survival In Chronic Myeloid Leukemia Patients: A Multicentric Cohort Study by the Italian CML GIMEMA Network
by: Giorgina Specchia, et al.
Published: (2021-08-01) -
OUR EXPERIENCE IN TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH IMATINIB MESYLATE
by: Marjana Glaser, et al.
Published: (2004-04-01) -
Comparative analysis of the Sokal, Euro and European Treatment and Outcome Study score in prognostication of Indian chronic myeloid leukemia-chronic phase patients on imatinib
by: Sunita Chhikara, et al.
Published: (2018-01-01) -
Comparison of Socal Score and Hasford Score Against the Response of Imatinib Mesylate Therapy in Patients with Chronic Granulocytic Leukemia in dr. Saiful Anwar Hospital Malang
by: Somarnam, et al.
Published: (2019-12-01)